Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2020-03-26 2020-01-24
Drug Identification Number 02418444 02418444
Brand name TEVA-RASAGILINE TEVA-RASAGILINE
Common or Proper name RASAGILINE 1MG TAB RASAGILINE 1MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients RASAGILINE RASAGILINE
Strength(s) 1MG 1MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code N04BD N04BD
ATC description DOPAMINERGIC AGENTS DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-15 2020-01-15
Estimated end date 2020-05-31 2020-03-31
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments